| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bortezomib | FIMM | pan-cancer | AAC | 0.19 | 0.2 |
| mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | BRD-K85133207 | CTRPv2 | pan-cancer | AAC | 0.05 | 0.2 |
| mRNA | MLN2238 | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | IOX2 | GDSC1000 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | CHM-1 | CTRPv2 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | BRD-K27224038 | CTRPv2 | pan-cancer | AAC | 0.096 | 0.2 |
| mRNA | CMK | GDSC1000 | pan-cancer | AAC | 0.074 | 0.2 |
| mRNA | BRD-K51490254 | CTRPv2 | pan-cancer | AAC | -0.05 | 0.2 |